Looking Back, Looking Forward: The Latest in Kidney Cancer Research

In January 2022, KidneyCAN hosted a Town Hall event to learn from leading experts about the latest #kidneycancer research news. Two renowned clinical kidney cancer researchers shared a retrospective of 2021 breakthroughs, along with a look forward at what we can expect in 2022. Dr. Martin Voss, a medical oncologist at Memorial Sloan Kettering Cancer Center, reviewed 2021 research breakthroughs and discussed their impact on patients' treatment options. Dr. Robert Uzzo, a urologic surgeon at Fox Chase Cancer Center, looked ahead at 2022 research and what patients can expect in the coming months. Following their presentations, the doctors took questions from patients all over the world. You can watch the full event here. To get notified when KidneyCAN has additional patient education or advocacy events, be sure to sign up for our newsletter at www.kidneycan.org. ————————————————————————— KidneyCAN works to accelerate cures for kidney cancer by providing patient support and education, encouraging enrollment in clinical trials, advocating for research funding from Congress, and sponsoring collaborative efforts between researchers and medical communities. To learn more about KidneyCAN: https://kidneycan.org​ Support our work: https://kidneycan.org/donate